| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aldosterone | 22 | 2023 | 881 | 2.600 |
Why?
|
| Anemia, Sickle Cell | 10 | 2023 | 1065 | 1.710 |
Why?
|
| Calmodulin-Binding Proteins | 8 | 2021 | 239 | 1.490 |
Why?
|
| Zona Glomerulosa | 7 | 2022 | 87 | 1.300 |
Why?
|
| Erythrocytes | 18 | 2022 | 2421 | 1.210 |
Why?
|
| Magnesium | 6 | 2022 | 816 | 1.120 |
Why?
|
| Endothelin-1 | 3 | 2023 | 296 | 1.070 |
Why?
|
| Renin-Angiotensin System | 4 | 2019 | 739 | 1.040 |
Why?
|
| Receptors, Mineralocorticoid | 11 | 2023 | 167 | 1.030 |
Why?
|
| TRPM Cation Channels | 3 | 2010 | 139 | 0.960 |
Why?
|
| Sodium Chloride, Dietary | 9 | 2024 | 301 | 0.910 |
Why?
|
| Hypertension | 12 | 2024 | 8615 | 0.900 |
Why?
|
| Angiotensin II | 6 | 2023 | 847 | 0.850 |
Why?
|
| Blood Pressure | 15 | 2024 | 8541 | 0.810 |
Why?
|
| Sodium, Dietary | 5 | 2020 | 426 | 0.790 |
Why?
|
| Sodium | 10 | 2023 | 1594 | 0.730 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2022 | 12241 | 0.670 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2021 | 348 | 0.650 |
Why?
|
| Nerve Tissue Proteins | 7 | 2021 | 4414 | 0.650 |
Why?
|
| Aminopeptidases | 1 | 2019 | 114 | 0.640 |
Why?
|
| Caloric Restriction | 2 | 2018 | 300 | 0.610 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2019 | 303 | 0.610 |
Why?
|
| Potassium | 11 | 2017 | 1318 | 0.590 |
Why?
|
| Diet, Sodium-Restricted | 2 | 2017 | 291 | 0.590 |
Why?
|
| Hemoglobin, Sickle | 5 | 2003 | 113 | 0.540 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 809 | 0.540 |
Why?
|
| Kidney | 7 | 2023 | 7064 | 0.510 |
Why?
|
| Endothelial Cells | 5 | 2023 | 3587 | 0.500 |
Why?
|
| Membrane Proteins | 7 | 2021 | 7880 | 0.480 |
Why?
|
| Vascular Diseases | 1 | 2023 | 1161 | 0.480 |
Why?
|
| Hemoglobin C | 4 | 2003 | 21 | 0.470 |
Why?
|
| Antiporters | 4 | 2012 | 276 | 0.470 |
Why?
|
| Resistin | 2 | 2016 | 172 | 0.450 |
Why?
|
| Insulin Resistance | 8 | 2018 | 3981 | 0.440 |
Why?
|
| Receptors, Calcium-Sensing | 2 | 2013 | 318 | 0.440 |
Why?
|
| Caveolin 1 | 5 | 2018 | 255 | 0.420 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2021 | 4357 | 0.370 |
Why?
|
| Overweight | 1 | 2022 | 2445 | 0.370 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2011 | 41 | 0.370 |
Why?
|
| Mice, Transgenic | 9 | 2023 | 9562 | 0.360 |
Why?
|
| Rats, Wistar | 6 | 2023 | 1890 | 0.350 |
Why?
|
| Sex Factors | 4 | 2020 | 10654 | 0.340 |
Why?
|
| Homeostasis | 9 | 2022 | 3349 | 0.320 |
Why?
|
| Chlorides | 3 | 2003 | 663 | 0.320 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2016 | 16028 | 0.300 |
Why?
|
| Mice | 29 | 2023 | 82017 | 0.300 |
Why?
|
| Kaempferols | 4 | 2009 | 22 | 0.300 |
Why?
|
| Kallidin | 2 | 2005 | 5 | 0.290 |
Why?
|
| Health | 1 | 2011 | 399 | 0.290 |
Why?
|
| Cardiovascular Diseases | 6 | 2022 | 15649 | 0.290 |
Why?
|
| Thrombosis | 1 | 2021 | 2955 | 0.290 |
Why?
|
| Animals | 46 | 2023 | 169337 | 0.290 |
Why?
|
| Insulin | 8 | 2017 | 6607 | 0.280 |
Why?
|
| Renin | 4 | 2017 | 648 | 0.280 |
Why?
|
| Estrogens | 1 | 2014 | 1534 | 0.280 |
Why?
|
| Parathyroid Hormone | 1 | 2013 | 1804 | 0.270 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 339 | 0.260 |
Why?
|
| RNA, Messenger | 9 | 2023 | 12805 | 0.250 |
Why?
|
| Gene Deletion | 1 | 2013 | 2673 | 0.250 |
Why?
|
| Mice, Knockout | 14 | 2023 | 14481 | 0.250 |
Why?
|
| Thiourea | 1 | 2005 | 68 | 0.240 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2005 | 90 | 0.240 |
Why?
|
| Myocardium | 6 | 2020 | 4788 | 0.240 |
Why?
|
| Blood Glucose | 7 | 2022 | 6430 | 0.240 |
Why?
|
| Immediate-Early Proteins | 2 | 2005 | 444 | 0.230 |
Why?
|
| Nucleotides | 2 | 2024 | 455 | 0.230 |
Why?
|
| Histone Demethylases | 2 | 2019 | 322 | 0.220 |
Why?
|
| Adiposity | 1 | 2013 | 1895 | 0.220 |
Why?
|
| Obesity | 5 | 2022 | 13084 | 0.220 |
Why?
|
| Telomerase | 1 | 2009 | 752 | 0.220 |
Why?
|
| Receptor, Endothelin A | 1 | 2023 | 55 | 0.210 |
Why?
|
| Quercetin | 3 | 2009 | 96 | 0.210 |
Why?
|
| Reactive Oxygen Species | 3 | 2022 | 2146 | 0.210 |
Why?
|
| Male | 44 | 2024 | 364902 | 0.210 |
Why?
|
| Glomerular Filtration Rate | 2 | 2022 | 2226 | 0.210 |
Why?
|
| NG-Nitroarginine Methyl Ester | 4 | 2023 | 262 | 0.210 |
Why?
|
| Purine Nucleotides | 1 | 2022 | 27 | 0.210 |
Why?
|
| Receptor, Endothelin B | 1 | 2022 | 46 | 0.210 |
Why?
|
| Genome | 1 | 2011 | 1747 | 0.200 |
Why?
|
| Xanthine Oxidase | 1 | 2022 | 69 | 0.200 |
Why?
|
| Symporters | 3 | 2001 | 363 | 0.200 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2002 | 43 | 0.200 |
Why?
|
| Calcium | 11 | 2013 | 5794 | 0.190 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2005 | 1658 | 0.190 |
Why?
|
| Dehydration | 1 | 2022 | 216 | 0.190 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2742 | 0.180 |
Why?
|
| Signal Transduction | 12 | 2020 | 23631 | 0.180 |
Why?
|
| Leukocytes | 1 | 2009 | 2030 | 0.180 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 838 | 0.170 |
Why?
|
| Major Histocompatibility Complex | 1 | 2023 | 877 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 9 | 2022 | 22355 | 0.170 |
Why?
|
| Bicarbonates | 1 | 2001 | 292 | 0.170 |
Why?
|
| C-Peptide | 1 | 2021 | 443 | 0.160 |
Why?
|
| Humans | 51 | 2024 | 768393 | 0.160 |
Why?
|
| Female | 31 | 2024 | 397089 | 0.160 |
Why?
|
| Random Allocation | 2 | 2021 | 2397 | 0.160 |
Why?
|
| Fibrin | 1 | 2021 | 514 | 0.160 |
Why?
|
| Brain Ischemia | 2 | 2009 | 3008 | 0.150 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2023 | 1438 | 0.150 |
Why?
|
| Osteoblasts | 4 | 2009 | 1154 | 0.150 |
Why?
|
| Arginine | 1 | 2002 | 923 | 0.150 |
Why?
|
| Lysine | 1 | 2022 | 988 | 0.150 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2017 | 55 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 2 | 2005 | 2003 | 0.140 |
Why?
|
| Hospital Mortality | 2 | 2022 | 5367 | 0.140 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 85 | 0.140 |
Why?
|
| Zona Reticularis | 1 | 2017 | 8 | 0.140 |
Why?
|
| Erythrocyte Membrane | 3 | 1997 | 438 | 0.140 |
Why?
|
| Case-Control Studies | 5 | 2021 | 22296 | 0.140 |
Why?
|
| Haplotypes | 3 | 2013 | 2724 | 0.140 |
Why?
|
| Uric Acid | 1 | 2022 | 806 | 0.130 |
Why?
|
| C-Reactive Protein | 2 | 2022 | 3857 | 0.130 |
Why?
|
| Risk Factors | 8 | 2022 | 74962 | 0.120 |
Why?
|
| Insulin-Secreting Cells | 2 | 2014 | 899 | 0.120 |
Why?
|
| Rats | 10 | 2023 | 23835 | 0.120 |
Why?
|
| Genetic Variation | 1 | 2010 | 6606 | 0.120 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 18362 | 0.120 |
Why?
|
| Fibroblasts | 2 | 2005 | 4177 | 0.120 |
Why?
|
| Biological Transport | 6 | 2003 | 2085 | 0.120 |
Why?
|
| Enzyme Inhibitors | 5 | 2013 | 3722 | 0.120 |
Why?
|
| Nitric Oxide Synthase | 2 | 2010 | 911 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2024 | 2066 | 0.110 |
Why?
|
| Stroke | 2 | 2023 | 9742 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2002 | 2611 | 0.110 |
Why?
|
| Triglycerides | 4 | 2016 | 2465 | 0.110 |
Why?
|
| Cations | 2 | 2013 | 240 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2021 | 975 | 0.110 |
Why?
|
| Caveolins | 1 | 2014 | 102 | 0.110 |
Why?
|
| Cytosol | 5 | 2005 | 886 | 0.110 |
Why?
|
| NAD | 1 | 2017 | 618 | 0.110 |
Why?
|
| Adiponectin | 2 | 2017 | 1117 | 0.110 |
Why?
|
| Carrier Proteins | 4 | 2024 | 4936 | 0.110 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1993 | 480 | 0.110 |
Why?
|
| Osmosis | 1 | 2013 | 103 | 0.110 |
Why?
|
| Kell Blood-Group System | 1 | 2012 | 21 | 0.100 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2012 | 39 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 18048 | 0.100 |
Why?
|
| Adult | 19 | 2021 | 223640 | 0.100 |
Why?
|
| Cations, Divalent | 1 | 2012 | 167 | 0.100 |
Why?
|
| Middle Aged | 16 | 2021 | 223491 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 4588 | 0.100 |
Why?
|
| Cell Membrane | 3 | 2013 | 3663 | 0.100 |
Why?
|
| Plant Extracts | 2 | 2022 | 499 | 0.100 |
Why?
|
| Cell Membrane Permeability | 2 | 2013 | 574 | 0.100 |
Why?
|
| Calcium-Transporting ATPases | 3 | 2012 | 122 | 0.100 |
Why?
|
| Fumarates | 1 | 2012 | 132 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 874 | 0.100 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2013 | 210 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2021 | 2660 | 0.090 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2559 | 0.090 |
Why?
|
| Interleukin-6 | 3 | 2022 | 3230 | 0.090 |
Why?
|
| Hormones | 1 | 2014 | 870 | 0.090 |
Why?
|
| Muscle Relaxation | 1 | 2010 | 138 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2010 | 706 | 0.090 |
Why?
|
| Amides | 1 | 2012 | 452 | 0.080 |
Why?
|
| Family Health | 1 | 2014 | 1255 | 0.080 |
Why?
|
| Genotype | 7 | 2017 | 13042 | 0.080 |
Why?
|
| Cells, Cultured | 5 | 2021 | 19022 | 0.080 |
Why?
|
| Hemoglobins, Abnormal | 2 | 1999 | 119 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2017 | 1627 | 0.080 |
Why?
|
| Erythrocyte Volume | 3 | 2013 | 28 | 0.080 |
Why?
|
| Protein Binding | 3 | 2014 | 9343 | 0.080 |
Why?
|
| Comorbidity | 2 | 2022 | 10588 | 0.080 |
Why?
|
| Spironolactone | 3 | 2020 | 412 | 0.080 |
Why?
|
| Blotting, Northern | 3 | 2005 | 1553 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2021 | 10117 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3252 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1901 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2005 | 826 | 0.070 |
Why?
|
| Calcimycin | 3 | 2013 | 214 | 0.070 |
Why?
|
| Inflammation | 2 | 2023 | 10863 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2010 | 1493 | 0.070 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2009 | 239 | 0.070 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2005 | 91 | 0.070 |
Why?
|
| Phenotype | 4 | 2014 | 16721 | 0.070 |
Why?
|
| Cardiomegaly | 1 | 2010 | 591 | 0.070 |
Why?
|
| Veins | 1 | 2011 | 768 | 0.070 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2009 | 781 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 703 | 0.070 |
Why?
|
| Apigenin | 1 | 2006 | 16 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 2296 | 0.070 |
Why?
|
| Cardiovascular System | 1 | 2014 | 838 | 0.070 |
Why?
|
| Kinetics | 6 | 2004 | 6333 | 0.070 |
Why?
|
| Arteries | 1 | 2011 | 1126 | 0.060 |
Why?
|
| Heart | 1 | 2019 | 4449 | 0.060 |
Why?
|
| Hemoglobin A | 2 | 2003 | 84 | 0.060 |
Why?
|
| Luciferases | 2 | 2005 | 712 | 0.060 |
Why?
|
| Epidemiologic Studies | 1 | 2009 | 678 | 0.060 |
Why?
|
| Bone Density | 2 | 2009 | 3559 | 0.060 |
Why?
|
| Leydig Cell Tumor | 1 | 2005 | 29 | 0.060 |
Why?
|
| Cell Count | 1 | 2009 | 1833 | 0.060 |
Why?
|
| Glucose | 1 | 2016 | 4352 | 0.060 |
Why?
|
| Erythrocyte Count | 2 | 2002 | 157 | 0.060 |
Why?
|
| Time Factors | 5 | 2020 | 40272 | 0.060 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 892 | 0.060 |
Why?
|
| Collagen | 2 | 2005 | 2646 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2023 | 54920 | 0.060 |
Why?
|
| Hypotonic Solutions | 1 | 2003 | 48 | 0.060 |
Why?
|
| Okadaic Acid | 1 | 2003 | 67 | 0.060 |
Why?
|
| Aorta | 1 | 2011 | 2046 | 0.060 |
Why?
|
| Family | 1 | 2014 | 3208 | 0.050 |
Why?
|
| Hemoglobins | 3 | 2002 | 1532 | 0.050 |
Why?
|
| Carboxylic Acids | 1 | 2003 | 91 | 0.050 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 2 | 2013 | 45 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2019 | 8326 | 0.050 |
Why?
|
| Indenes | 1 | 2003 | 59 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2006 | 10776 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 2027 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2022 | 81801 | 0.050 |
Why?
|
| Telomere | 1 | 2009 | 943 | 0.050 |
Why?
|
| Cytokines | 1 | 2017 | 7445 | 0.050 |
Why?
|
| Nitrates | 1 | 2003 | 260 | 0.050 |
Why?
|
| Osteoclasts | 1 | 2006 | 712 | 0.050 |
Why?
|
| Protein Kinase C | 3 | 2008 | 1207 | 0.050 |
Why?
|
| Reticulocytes | 4 | 2000 | 288 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2021 | 12166 | 0.050 |
Why?
|
| Citrulline | 1 | 2002 | 107 | 0.050 |
Why?
|
| Secretory Pathway | 1 | 2021 | 53 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2008 | 1122 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 59686 | 0.050 |
Why?
|
| Mexico | 2 | 2014 | 767 | 0.050 |
Why?
|
| Aged | 8 | 2021 | 171562 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2011 | 6350 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2005 | 637 | 0.050 |
Why?
|
| Pravastatin | 1 | 2023 | 393 | 0.050 |
Why?
|
| Antioxidants | 1 | 2009 | 1673 | 0.050 |
Why?
|
| Receptors, Bradykinin | 1 | 2000 | 19 | 0.040 |
Why?
|
| Simvastatin | 1 | 2023 | 346 | 0.040 |
Why?
|
| Ion Transport | 3 | 2012 | 322 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 11918 | 0.040 |
Why?
|
| Globins | 2 | 2000 | 405 | 0.040 |
Why?
|
| Growth Substances | 2 | 2000 | 761 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 30022 | 0.040 |
Why?
|
| Microcirculation | 1 | 2005 | 1282 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2006 | 1416 | 0.040 |
Why?
|
| Models, Animal | 2 | 2010 | 2124 | 0.040 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2011 | 153 | 0.040 |
Why?
|
| Cell Line | 5 | 2006 | 15597 | 0.040 |
Why?
|
| Hemoglobinopathies | 1 | 1999 | 101 | 0.040 |
Why?
|
| Cell Division | 1 | 2006 | 4479 | 0.040 |
Why?
|
| Testicular Neoplasms | 1 | 2005 | 805 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2002 | 646 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2009 | 2589 | 0.040 |
Why?
|
| Charybdotoxin | 1 | 1997 | 23 | 0.040 |
Why?
|
| Gene Expression | 4 | 2021 | 7598 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2017 | 41795 | 0.040 |
Why?
|
| Ionophores | 1 | 1997 | 108 | 0.040 |
Why?
|
| Sulfones | 1 | 2020 | 448 | 0.040 |
Why?
|
| Potassium Channel Blockers | 1 | 1997 | 162 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2014 | 13052 | 0.030 |
Why?
|
| Sirolimus | 1 | 2024 | 1542 | 0.030 |
Why?
|
| Aldehyde Reductase | 1 | 2016 | 70 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.030 |
Why?
|
| Young Adult | 4 | 2017 | 60049 | 0.030 |
Why?
|
| Ovariectomy | 2 | 2009 | 615 | 0.030 |
Why?
|
| Corticosterone | 1 | 2017 | 301 | 0.030 |
Why?
|
| Ouabain | 2 | 1993 | 246 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 24318 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2005 | 2144 | 0.030 |
Why?
|
| Fasting | 1 | 2002 | 1610 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2014 | 26375 | 0.030 |
Why?
|
| Blotting, Western | 3 | 2014 | 5037 | 0.030 |
Why?
|
| Albuminuria | 1 | 2019 | 658 | 0.030 |
Why?
|
| RNA | 1 | 2005 | 2726 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1993 | 2087 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 309 | 0.030 |
Why?
|
| Pyrroles | 1 | 2020 | 1126 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2016 | 293 | 0.030 |
Why?
|
| Acanthocytes | 1 | 2012 | 3 | 0.030 |
Why?
|
| Neuroacanthocytosis | 1 | 2012 | 6 | 0.030 |
Why?
|
| Endothelin-3 | 1 | 2012 | 9 | 0.030 |
Why?
|
| Abetalipoproteinemia | 1 | 2012 | 16 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 2013 | 121 | 0.030 |
Why?
|
| Receptors, Endothelin | 1 | 2012 | 56 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1994 | 243 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1997 | 1684 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1993 | 323 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2013 | 767 | 0.030 |
Why?
|
| Chemokines, CXC | 1 | 1994 | 420 | 0.020 |
Why?
|
| Syndrome | 1 | 1998 | 3275 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 682 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2013 | 296 | 0.020 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2011 | 18 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 6085 | 0.020 |
Why?
|
| Polymorphism, Genetic | 2 | 2017 | 4250 | 0.020 |
Why?
|
| Adipose Tissue | 2 | 2016 | 3334 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1993 | 617 | 0.020 |
Why?
|
| Hemolysis | 1 | 2012 | 418 | 0.020 |
Why?
|
| Oxygen | 1 | 2002 | 4273 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2006 | 3431 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2016 | 3617 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2010 | 293 | 0.020 |
Why?
|
| Ginkgo biloba | 1 | 2009 | 26 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 1183 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2011 | 4142 | 0.020 |
Why?
|
| alpha-Thalassemia | 2 | 1999 | 53 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2016 | 873 | 0.020 |
Why?
|
| Prediabetic State | 1 | 2014 | 548 | 0.020 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2012 | 386 | 0.020 |
Why?
|
| Rabbits | 2 | 2011 | 4781 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 2011 | 519 | 0.020 |
Why?
|
| Epigenomics | 1 | 2014 | 959 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2010 | 629 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 208 | 0.020 |
Why?
|
| Cholesterol | 1 | 2016 | 2912 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2008 | 287 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2010 | 594 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2009 | 8199 | 0.020 |
Why?
|
| Erythrocyte Indices | 2 | 2000 | 143 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2008 | 199 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2011 | 943 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 657 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2008 | 385 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1110 | 0.020 |
Why?
|
| Femur Neck | 1 | 2008 | 318 | 0.020 |
Why?
|
| Adipokines | 1 | 2008 | 309 | 0.020 |
Why?
|
| Vasodilation | 1 | 2010 | 968 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 990 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 615 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 11516 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2008 | 487 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 11221 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1755 | 0.010 |
Why?
|
| Liver | 2 | 2016 | 7574 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2005 | 455 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 826 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 657 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 515 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1993 | 6510 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2005 | 1305 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1994 | 298 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2014 | 4199 | 0.010 |
Why?
|
| Adolescent | 5 | 2016 | 89184 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 413 | 0.010 |
Why?
|
| Heterozygote | 2 | 1999 | 2791 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3139 | 0.010 |
Why?
|
| Tibia | 1 | 2008 | 1075 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18471 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2011 | 4291 | 0.010 |
Why?
|
| DNA Primers | 1 | 2006 | 2825 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 1742 | 0.010 |
Why?
|
| Neutrophils | 1 | 1994 | 3785 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2008 | 1295 | 0.010 |
Why?
|
| Adipocytes | 1 | 2008 | 1200 | 0.010 |
Why?
|
| Breeding | 1 | 2000 | 51 | 0.010 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2000 | 24 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 2414 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2695 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2000 | 189 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2000 | 342 | 0.010 |
Why?
|
| Founder Effect | 1 | 2000 | 185 | 0.010 |
Why?
|
| Leptin | 1 | 2008 | 1597 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2008 | 4039 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2006 | 2079 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2008 | 11668 | 0.010 |
Why?
|
| Splenectomy | 1 | 2000 | 392 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2008 | 1885 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2000 | 946 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13423 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1997 | 81 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1997 | 166 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 4120 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 3164 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 2000 | 605 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 1997 | 113 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11120 | 0.010 |
Why?
|
| Body Weight | 1 | 2008 | 4629 | 0.010 |
Why?
|
| Diglycerides | 1 | 1997 | 176 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 17626 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6234 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2006 | 2593 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2000 | 1539 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3794 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 9261 | 0.010 |
Why?
|
| Prevalence | 1 | 2013 | 15872 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1997 | 429 | 0.010 |
Why?
|
| Erythrocyte Aging | 1 | 1994 | 53 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1997 | 2172 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 12422 | 0.010 |
Why?
|
| beta-Thromboglobulin | 1 | 1994 | 20 | 0.010 |
Why?
|
| Osmotic Pressure | 1 | 1994 | 137 | 0.010 |
Why?
|
| Receptors, Interleukin-8A | 1 | 1994 | 47 | 0.010 |
Why?
|
| Risk | 1 | 2006 | 9636 | 0.010 |
Why?
|
| Mutation | 1 | 1998 | 30228 | 0.010 |
Why?
|
| Chemokine CXCL1 | 1 | 1994 | 102 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2002 | 1841 | 0.010 |
Why?
|
| Platelet Factor 4 | 1 | 1994 | 132 | 0.010 |
Why?
|
| Chemotactic Factors | 1 | 1994 | 197 | 0.010 |
Why?
|
| Cell Size | 1 | 1994 | 626 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1993 | 422 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1993 | 254 | 0.010 |
Why?
|
| Phosphorus | 1 | 1993 | 336 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 12456 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1997 | 3587 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 5708 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 17135 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1993 | 584 | 0.010 |
Why?
|
| Pedigree | 1 | 1998 | 4544 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 1994 | 705 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 5796 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 1992 | 0.010 |
Why?
|
| Cricetinae | 1 | 1994 | 2423 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 4941 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2000 | 2929 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1991 | 209 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1994 | 2488 | 0.010 |
Why?
|
| Smoking | 1 | 2006 | 9111 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 10377 | 0.000 |
Why?
|
| Fetal Hemoglobin | 1 | 1991 | 346 | 0.000 |
Why?
|
| Physicians | 1 | 2006 | 4614 | 0.000 |
Why?
|
| Adenosine Triphosphate | 1 | 1993 | 2002 | 0.000 |
Why?
|
| Transfection | 1 | 1994 | 5764 | 0.000 |
Why?
|
| Cell Separation | 1 | 1991 | 1726 | 0.000 |
Why?
|
| Peptides | 1 | 1994 | 4353 | 0.000 |
Why?
|
| Lung | 1 | 2000 | 10089 | 0.000 |
Why?
|
| Child | 2 | 1999 | 80891 | 0.000 |
Why?
|
| United States | 1 | 2006 | 73150 | 0.000 |
Why?
|